CLINICAL RESEARCH: VALVULAR HEART DISEASE
Clinical Factors, But Not C-Reactive Protein, Predict Progression of Calcific Aortic-Valve DiseaseThe Cardiovascular Health Study
Gian M. Novaro, MD*,*,
Ronit Katz, PhD ,
Ronnier J. Aviles, MD ,
John S. Gottdiener, MD ,
Mary Cushman, MD, MSc||,
Bruce M. Psaty, MD, PhD¶,
Catherine M. Otto, MD# and
Brian P. Griffin, MD**
* Department of Cardiology, Cleveland Clinic Florida, Weston, Florida
Department of Biostatistics, University of Washington, Seattle, Washington
Overlake Hospital Medical Center, Bellevue, Washington
Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland
|| Department of Medicine, University of Vermont and Fletcher Allen Health Care, Colchester, Vermont
¶ Departments of Medicine, Epidemiology and Health Services, University of Washington, Seattle, Washington
# Department of Cardiology, University of Washington, Seattle, Washington
** Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
Manuscript received May 25, 2007;
revised manuscript received July 30, 2007,
accepted July 30, 2007.
* Reprint requests and correspondence: Dr. Gian M. Novaro, Department of Cardiology, Desk A23, Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, Florida 33331. (Email: novarog{at}ccf.org).
Objectives: The purpose of this study was to examine the relationship between C-reactive protein (CRP) and calcific aortic valve disease in a large, randomly selected, population-based cohort.
Background: The pathobiology of calcific aortic stenosis involves an active inflammatory, atheromatous, osteogenic process. Elevations in CRP, a measure of systemic inflammation, have been associated with aortic stenosis.
Methods: Two-dimensional and Doppler echocardiography and CRP measurement were performed at baseline in 5,621 participants in the Cardiovascular Health Study. Multivariable analysis was used to identify CRP as a predictor of baseline and incident aortic stenosis.
Results: At a mean echocardiographic follow-up of 5 years, 9% of subjects with aortic sclerosis progressed to some degree of aortic stenosis. Increasing age (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.09 to 1.16; p < 0.001) and male gender (OR 3.05, 95% CI 1.76 to 5.27; p < 0.001) were related to risk of incident aortic stenosis, whereas increasing height (OR 0.96, 95% CI 0.94 to 0.99; p = 0.013) and African-American ethnicity conveyed a lower risk (OR 0.49, 95% CI 0.25 to 0.95; p = 0.035). C-reactive protein, treated as a continuous variable, was not associated with baseline aortic stenosis, progression to aortic sclerosis (adjusted OR 0.93, 95% CI 0.85 to 1.02; p = 0.107), or progression to aortic stenosis (adjusted OR 0.85, 95% CI 0.70 to 1.03; p = 0.092).
Conclusions: In this large population-based cohort, approximately 9% of subjects with aortic sclerosis progressed to aortic stenosis over a 5-year follow-up period. There was no association between CRP levels and the presence of calcific aortic-valve disease or incident aortic stenosis. C-reactive protein appears to be a poor predictor of subclinical calcific aortic-valve disease.
|
Abbreviations and Acronyms
| | CI = confidence interval | | CRP = C-reactive protein | | OR = odds ratio |
|
Related Article
-
C-Reactive Protein to Identify Early Risk for Development of Calcific Aortic Stenosis: Right Marker? Wrong Time?
- Peter H. Stone
J. Am. Coll. Cardiol. 2007 50: 1999-2001.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. Koos, V. Brandenburg, A. H. Mahnken, G. Muhlenbruch, S. Stanzel, R. W. Gunther, J. Floege, W. Jahnen-Dechent, M. Kelm, and H. P. Kuhl
Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients
Eur. Heart J.,
August 2, 2009;
30(16):
2054 - 2061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Otto
Calcific aortic valve disease: outflow obstruction is the end stage of a systemic disease process
Eur. Heart J.,
August 2, 2009;
30(16):
1940 - 1942.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Stritzke, P. Linsel-Nitschke, M. R. P. Markus, B. Mayer, W. Lieb, A. Luchner, A. Doring, W. Koenig, U. Keil, H.-W. Hense, et al.
Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey
Eur. Heart J.,
August 2, 2009;
30(16):
2044 - 2053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T.M. Ngo, A. L. Sverdlov, S. R. Willoughby, A. K. Nightingale, Y. Y. Chirkov, J. J. McNeil, and J. D. Horowitz
Determinants of Occurrence of Aortic Sclerosis in an Aging Population
J. Am. Coll. Cardiol. Img.,
August 1, 2009;
2(8):
919 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Greve and K. Wachtell
Review: Does lowering cholesterol have an impact on the progression of aortic stenosis?
Therapeutic Advances in Cardiovascular Disease,
August 1, 2008;
2(4):
277 - 286.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bosse, P. Mathieu, and P. Pibarot
Genomics: The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1327 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Stone
C-Reactive Protein to Identify Early Risk for Development of Calcific Aortic Stenosis: Right Marker? Wrong Time?
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
1999 - 2001.
[Full Text]
[PDF]
|
 |
|
|